financetom
Business
financetom
/
Business
/
European Commission to launch investigation into Temu, Bloomberg reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
European Commission to launch investigation into Temu, Bloomberg reports
Nov 3, 2024 3:11 PM

LONDON, Oct 30 (Reuters) - The European Commission is

set to launch an investigation into Chinese online retail

platform Temu over whether it is in breach of rules meant to

prevent the sale of illegal products online, Bloomberg News

reported on Wednesday, citing unnamed sources.

The report follows the Commission's Oct. 11 request for

information from Temu under the Digital Services Act, asking

what steps it is taking to stop illegal products being sold on

its platform.

Temu, a unit of PDD Holdings ( PDD ), had to provide the

information by Oct. 21. The Commission at the time said it would

"determine the next steps" after assessing Temu's responses.

Under the European Union's Digital Services Act, companies

with more than 45 million users are designated "very large

online platforms" (VLOPs) and are required to do more to fight

illegal content as well as counterfeit products on their

platforms.

The Commission designated Temu a VLOP in May.

The European Commission declined to comment on the Bloomberg

report. A Temu spokesperson did not immediately reply to a

request for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved